Aspira Other Tuesday, May 26, 2026 +0.50 Positive

Aspira Women's Health enters master collaboration agreement with Cleveland Clinic Foundation

Aspira Women's Health Inc. has entered into a Master Collaboration and License Agreement with The Cleveland Clinic Foundation for biomedical research and development projects in women's health diagnostics. The partnership leverages CCF's research capabilities and Aspira's diagnostic expertise to advance mutual research interests.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day